{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q17103",
      "entity_text" : "c-MYC",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0147" ]
    }
  },
  "verbose_text" : "The c-MYC TF is an attractive target for cancer therapy because of the role that excessive c-MYC levels play in a broad spectrum of aggressive cancers, but direct pharmacologic inhibition of c-MYC remains an elusive challenge in drug discovery.",
  "reading_complete" : "2020-08-08T17:01:43Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T17:00:31Z",
  "trigger" : "levels",
  "evidence" : [ "c-MYC levels" ],
  "pmc_id" : "5929158",
  "score" : 0
}